Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSB1600009 | 注射用重组人源化抗人肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products | Supplementary Application | 2016-09-05 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-11-17 | view |
CXSB1600010 | 注射用重组人源化抗人肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products | Supplementary Application | 2016-09-05 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-11-17 | view |